United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-177_b4d4d6f0-2b78-4882-add2-7c6218270b7f
- Product NDC
- 67877-177
- Form
- TABLET
- Composition / generic term
- Olanzapine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120101
- Source listing expiry
- 20261231
Source-listed ingredients
- OLANZAPINE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (67877-177-01) · 67877-177-01
- 1000 TABLET in 1 BOTTLE (67877-177-10) · 67877-177-10
- 30 TABLET in 1 BOTTLE (67877-177-30) · 67877-177-30
- 10 BLISTER PACK in 1 CARTON (67877-177-35) / 10 TABLET in 1 BLISTER PACK (67877-177-33) · 67877-177-35
- 7 TABLET in 1 BOTTLE (67877-177-37) · 67877-177-37
- 3 BLISTER PACK in 1 CARTON (67877-177-85) / 10 TABLET in 1 BLISTER PACK (67877-177-33) · 67877-177-85
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →